drugset / Trial / NCT02709187
DP-R208 Pharmacokinetic Study
RandomizedCrossoverOpen-labelTreatment
Summary
An open label, randomized, 2-sequence, 2-period, single-dose cross-over study to evaluate the pharmacokinetics characteristics of DP-R208 (Candesartan cilexetil 8mg/Rosuvastatin 10mg), a fixed dose combination compared with coadministration of separate constituents in healthy adult volunteers
Timeline
- Start
- 2016-03
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Candesartan cilexetil | Unknown | 8 mg | — |
| Subject | DP-R208 | Unknown | — | — |
| Subject | Rosuvastatin | Small molecule | 10 mg | — |
Indications
No indication recorded.